Skip to content

SAREPTA THERAPEUTICS, INC.: filings

Every SAREPTA THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026491390001193125-26-335003
10-Q2026-05-06fiscal Q1 2026491030001193125-26-208893
10-K2026-03-02fiscal FY 2025601960001193125-26-084144
10-Q2025-11-06fiscal Q3 2025501430001193125-25-269436
10-Q2025-08-06fiscal Q2 2025481350000950170-25-103971
10-Q2025-05-06fiscal Q1 202547990000950170-25-064412
10-K2025-02-28fiscal FY 2024551430000950170-25-029973
10-Q2024-11-06fiscal Q3 2024481390000950170-24-122239
10-Q2024-08-07fiscal Q2 2024481350000950170-24-092720
10-Q2024-05-01fiscal Q1 202448990000950170-24-051234
10-K2024-02-28fiscal FY 2023551430000950170-24-022036
10-Q2023-11-01fiscal Q3 2023481390000950170-23-057414
10-Q2023-08-02fiscal Q2 2023471330000950170-23-037125
10-Q2023-05-02fiscal Q1 202347970000950170-23-016654
10-K2023-02-28fiscal FY 2022551430000950170-23-005062
10-Q2022-11-02fiscal Q3 2022471370000950170-22-021213
10-Q2022-08-02fiscal Q2 2022461310000950170-22-013863
10-Q2022-05-04fiscal Q1 202244910000950170-22-007375
10-K2022-03-01fiscal FY 2021531360000950170-22-002517
10-Q2021-11-03fiscal Q3 2021441270000950170-21-002815
10-Q2021-08-04fiscal Q2 2021441230001564590-21-040787
10-Q2021-05-05fiscal Q1 202144910001564590-21-024018
10-K2021-03-01fiscal FY 2020542190001564590-21-009835
10-Q2020-11-05fiscal Q3 2020451280001564590-20-051308
10-Q2020-08-05fiscal Q2 2020451240001564590-20-036794
10-Q2020-05-06fiscal Q1 202045910001564590-20-021905
10-K2020-02-26fiscal FY 2019532150001564590-20-006769
10-Q2019-11-07fiscal Q3 2019481310001564590-19-041709
10-Q2019-08-07fiscal Q2 2019491310001564590-19-030035
10-Q2019-05-08fiscal Q1 201948940001564590-19-017175
10-K2019-02-28fiscal FY 2018532240001564590-19-005170
10-Q2018-10-31fiscal Q3 2018451180001564590-18-025831
10-Q2018-08-08fiscal Q2 2018461250001564590-18-020534
10-Q2018-05-03fiscal Q1 201840800001564590-18-010662
10-K2018-03-01fiscal FY 2017431780001564590-18-004107
10-Q2017-11-01fiscal Q3 201737930001564590-17-020808
10-Q2017-08-03fiscal Q2 2017381000001564590-17-015393
10-Q2017-05-04fiscal Q1 201737720001564590-17-008747
10-K2017-02-28fiscal FY 2016381450001564590-17-002842
10-Q2016-11-07fiscal Q3 201633840001564590-16-027821
10-Q2016-08-09fiscal Q2 201631800001564590-16-023663
10-Q2016-05-05fiscal Q1 201630610001564590-16-017783
10-K2016-02-25fiscal FY 2015361470001564590-16-013358
10-Q2015-11-05fiscal Q3 201530800001564590-15-009495
10-Q2015-08-06fiscal Q2 201531810001193125-15-279829
10-Q2015-05-07fiscal Q1 201530610001193125-15-175829
10-K2015-02-26fiscal FY 2014361460001193125-15-063997
10-Q2014-11-06fiscal Q3 201430780001193125-14-399619
10-Q2014-08-07fiscal Q2 201430770001193125-14-299374
10-Q2014-05-08fiscal Q1 201430710001193125-14-188608
10-K2014-03-03fiscal FY 2013371590001193125-14-080447
10-Q2013-11-12fiscal Q3 201331940001193125-13-436840
10-Q2013-08-08fiscal Q2 201331930001193125-13-325439
10-Q2013-05-09fiscal Q1 201328690001193125-13-211458
10-K2013-03-15fiscal FY 2012351610001193125-13-109941
10-Q2012-11-07fiscal Q3 201231980001193125-12-457533
10-Q2012-08-07fiscal Q2 201230950001193125-12-340912
10-Q2012-05-10fiscal Q1 201230750001193125-12-223884
10-K2012-03-13fiscal FY 201131940001193125-12-112142
10-Q2011-11-08fiscal Q3 201125720001193125-11-302239
10-Q2011-08-08fiscal Q2 201129880001193125-11-214459

Inspect the source

Entity
SAREPTA THERAPEUTICS, INC. / CIK 0000873303
Captured
2026-09-20T05:00:35.473Z
SEC response SHA-256
73fbffcbdadfe28b857d7fca50ab4aac61e15003102807aade5f366cc35bb6b9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000873303.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))